Structure‐Based Development of a Covalent Inhibitor Targeting Streptococcus Pyogenes over Staphylococcus Aureus Sortase A
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202500464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Hailing Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Centre for Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 2012…. Hauptthemen laut MEDLINE: Aminoacyltransferases, Cysteine Endopeptidases, Streptococcus pyogenes, Bacterial Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Youth Innovation Promotion Association of CAS.
Abstract (Originalsprache)
Sortase A (SrtA), a cysteine transpeptidase critical for surface protein anchoring in Gram‐positive pathogens, represents an attractive antivirulence target. While covalent SrtA inhibitors show therapeutic potential, existing compounds lack species selectivity. Through structure‐guided design, we developed T10 , a covalent inhibitor selectively targeting Streptococcus pyogenes SrtA ( Sp SrtA) over Staphylococcus aureus SrtA ( Sa SrtA). Molecular docking revealed that shortening a “C=C” bond in lead compound ML346 eliminated Sa SrtA inhibition due to steric hindrance from W194, while maintaining Sp SrtA binding. X‐ray crystallography confirmed T10 ′s covalent modification of Cys208 in Sp SrtA. T10 demonstrated two fold enhanced inhibitory potency and species‐specific disruption of M‐protein anchoring and biofilm formation in Streptococcus pyogenes , without affecting Staphylococcus aureus viability. In a Galleria mellonella infection model, T10 conferred potent protection against lethal infection. This work demonstrates the development of narrow‐spectrum antivirulence agents through a structure‐based rational strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research, Centre for Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, China.
- School of Life Sciences, Fudan University, Shanghai, 200433, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, 264117, China.
ORCID-Profile: Tao Zhang, Cai-Guang Yang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Youth Innovation Promotion Association of CAS
Zitieren
APA
Zhou, H., Yuan, Z., Guan, X. N., Yue, C., Wu, W., Lan, L., Gan, J., Zhang, T., & Yang, C. G. (2025). Structure‐Based Development of a Covalent Inhibitor Targeting Streptococcus Pyogenes over Staphylococcus Aureus Sortase A. Chemistry – A European Journal. https://doi.org/10.1002/chem.202500464
Vancouver
Zhou H, Yuan Z, Guan XN, Yue C, Wu W, Lan L, et al. Structure‐Based Development of a Covalent Inhibitor Targeting Streptococcus Pyogenes over Staphylococcus Aureus Sortase A. Chemistry – A European Journal. 2025. doi:10.1002/chem.202500464
BibTeX
@article{Zhou2025,
author = {Zhou, Hailing and Yuan, Ziqi and Guan, Xiang-Na and Yue, Chuan and Wu, Wei and Lan, Lefu and Gan, Jianhua and Zhang, Tao and Yang, Cai-Guang},
title = {Structure‐Based Development of a Covalent Inhibitor Targeting Streptococcus Pyogenes over Staphylococcus Aureus Sortase A},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202500464}
}
EUVIMED